-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The State Food and Drug Administration revealed that a chain pharmacy was fined 1.
25 million yuan for illegally purchasing drugs, and the legal person was banned from business for life
.
According to the requirements of the State Food and Drug Administration, starting this month, the special inspection of pharmacies will start for a period of 8 months
.
A chain of pharmacies was fined 1.
25 million yuan Recently, the State Food and Drug Administration announced 5 typical cases of special drug safety rectification, in which a chain pharmacy was fined 1.
25 million yuan for illegal drug purchases and other issues
.
According to the announcement, in October 2021, the Liaoning Provincial Food and Drug Administration found that Shenyang Shengjing Guoda Pharmacy Chain Co.
, Ltd.
mainly committed the following illegal acts: 1.
Not purchasing from drug marketing license holders or enterprises with drug production and business qualifications” Jingling Oral Liquid" medicine
.
2.
Fabricating purchase records in the computer system, failing to ask for an invoice from the supplier when purchasing drugs, and untraceable drug purchase, storage, and distribution information,
etc.
3.
Zhao Moulin, the legal representative, never actually worked in the company and failed to perform relevant management responsibilities
.
According to the relevant provisions of the new "Drug Administration Law", drug distribution enterprises that fail to comply with the drug distribution quality management standards shall be ordered to make corrections within a time limit and given a warning; those who fail to make corrections within the time limit shall be fined not less than 100,000 yuan but not more than 500,000 yuan; if the circumstances are serious A fine of not less than 500,000 yuan but not more than 2 million yuan shall be imposed
; If a drug dealer fails to purchase drugs from an enterprise qualified for drug dealership, it shall be ordered to make corrections, the illegally purchased drugs and illegal income shall be confiscated, and a fine of not less than two times but not more than ten times the value of the illegally purchased drugs shall be imposed; if the circumstances are serious, A fine of not less than ten times but not more than 30 times the value of the goods shall be imposed, and the drug business license shall be revoked; if the value of the goods is less than 50,000 yuan, it shall be calculated as 50,000 yuan
.
In January 2022, the Liaoning Provincial Food and Drug Administration imposed a fine of 1.
25 million yuan on the chain pharmacy in accordance with the above-mentioned regulations, and imposed an administrative penalty on the company's legal representative to ban the company's legal representative from engaging in drug production and business activities for life
.
Illegal drug purchases frequently occur
.
On April 13, the Yunnan Food and Drug Administration announced a number of typical cases.
A chain pharmacy was fined 1 million yuan for failing to establish true and complete purchase and sales records and for failing to achieve full control of related drugs
.
On March 22, a news from China.
com.
cn reported that a chain pharmacy in Guangzhou had been queuing up to buy prepared medicines from a medical mechanism and sold them online.
It was suspected of illegally buying and selling medicines, and was fined nearly 600,000 yuan by the regulatory authorities on March 2, According to the Consumer Quality News, a pharmacy in Jinniu District, Chengdu purchased atorvastatin, rosuvastatin and other drugs from personal channels, and was filed by the regulatory authorities, and the illegal gains were confiscated and fined 100,000 yuan
.
Why does this kind of phenomenon happen so often? With this question in mind, Cyberblue - pharmacy managers consulted relevant people and learned that some pharmacies usually take risks and take the initiative to illegally purchase drugs in order to obtain higher profits
.
Take the example of "incomplete information on drug purchases" in illegal drug purchases, which are generally related to three illegal acts of pharmacies: 1.
Illegal collusion
.
Many medicines are controlled for sale, and the prices are different in different regions.
Pharmacies choose to buy low-priced types of drugs, and the drugs that are sold do not carry invoices, which leads to incomplete drug purchase information in pharmacies
.
2.
Purchase of recycled medicines
.
Pharmacies buy recycled medicines from drug dealers at low prices (drugs that are re-entered into the market through medical insurance coverage), most of these drugs are chronic disease medical insurance drugs, purchased and sold through formal channels, pharmacy profit Weibo, some drugs even negative gross profit, If it is replaced with recycled drugs, the gross profit can be increased to about 30%.
Since chronic disease drugs are the main category, the profit of pharmacies selling recycled drugs is considerable
.
3.
Peer purchase
.
Some medicines are only available in their peers, and they are sold very cheaply.
Pharmacies may purchase them as customers through online platforms, and then put them in their own stores for secondary sales
.
However, there is one more special reason
.
Some pharmacies disrupted the market price order, and were stopped by upstream channels due to sales control regulations.
In order to keep their sales share, pharmacies had to continue to mix products.
.
In addition, some chain pharmacies will take unfair competition measures in the face of competitors dumping drugs at low prices, and buy a large number of dumped drugs, so as to deplete the gross profit of competitors' stores.
It also belongs to "illegal drug purchase"
.
The special inspection starts for 8 months.
Recently, the Drug Supervision Department of the State Food and Drug Administration held a working meeting on the special inspection of drug distribution and use
.
The meeting requested that in 2022, the supervision of drug operation should focus on 6 tasks, including "strict investigation and severe punishment, and comprehensive implementation of special inspection requirements for operation and use"
.
In this context, many provinces across the country have successively released the 2022 drug business inspection work plan.
For retail pharmacies, the plan includes a number of special inspections such as "purchasing and selling links", and some provinces have also clarified the special inspection cycle, which is generally 8 months
.
On April 24, the Jiangsu Food and Drug Administration issued an announcement requiring the deployment of special inspections on drug distribution and use.
This special inspection will last for 8 months, starting in April and ending in November
.
The Jiangsu Food and Drug Administration emphasized that it should focus on the source of drug purchases, and focus on the purchase and sale of illegal channels, fraudulent purchases of state-controlled drugs, etc.
Issues such as purchasing medicines by licensed entities and individuals, operating medicines beyond the scope of business, exceeding business methods, and fictitious sources of medicines
.
A few days ago, the Shandong Provincial Food and Drug Administration issued the "Provincial Drug Operation Special Inspection Work Plan", stating that it is necessary to organize a special inspection of drug operation throughout the province, of which "drug purchase sources" are one of the key points of the inspection
.
According to the requirements of the document, the special inspection should be completed before the end of November this year, with a cycle of about 8 months
.
According to incomplete statistics, Jiangsu, Shandong, Shanxi, Ningxia, Liaoning, Shaanxi and other provinces and cities have released 2022 drug business inspection plans, all requiring regulatory authorities to strictly inspect drug purchases and sales in pharmacies
.
In addition, according to the relevant provisions of the new "Drug Administration Law", pharmacies who purchase drugs from illegal channels will be fined at least 100,000 yuan; if the circumstances are serious, the fine will start at 500,000 yuan.
.
In order to avoid heavy fines caused by "illegal channel purchase of drugs", pharmacies must pay attention to the following points when purchasing drugs: 1.
Carefully check the relevant qualifications of the enterprises that purchase drugs, and must ensure that the pharmacies are purchased from qualified enterprises.
Purchase of medicines (except for the purchase of Chinese herbal medicines that have not been subject to approval management)
.
2.
For the purchase of drugs, a purchase inspection and acceptance system shall be established and implemented, and the drug qualification certificate and other marks shall be verified.
If the drug does not meet the prescribed requirements, it shall not be purchased and sold
.
3.
Pharmacies should have true and complete purchase and sales records, including the generic name of the drug, dosage form, specifications, product batch number, expiration date, marketing license holder, manufacturer, purchase and sale unit, purchase and sale quantity, purchase and sale price, purchase and sale date and Other contents stipulated by the drug regulatory department of the State Council
.
25 million yuan for illegally purchasing drugs, and the legal person was banned from business for life
.
According to the requirements of the State Food and Drug Administration, starting this month, the special inspection of pharmacies will start for a period of 8 months
.
A chain of pharmacies was fined 1.
25 million yuan Recently, the State Food and Drug Administration announced 5 typical cases of special drug safety rectification, in which a chain pharmacy was fined 1.
25 million yuan for illegal drug purchases and other issues
.
According to the announcement, in October 2021, the Liaoning Provincial Food and Drug Administration found that Shenyang Shengjing Guoda Pharmacy Chain Co.
, Ltd.
mainly committed the following illegal acts: 1.
Not purchasing from drug marketing license holders or enterprises with drug production and business qualifications” Jingling Oral Liquid" medicine
.
2.
Fabricating purchase records in the computer system, failing to ask for an invoice from the supplier when purchasing drugs, and untraceable drug purchase, storage, and distribution information,
etc.
3.
Zhao Moulin, the legal representative, never actually worked in the company and failed to perform relevant management responsibilities
.
According to the relevant provisions of the new "Drug Administration Law", drug distribution enterprises that fail to comply with the drug distribution quality management standards shall be ordered to make corrections within a time limit and given a warning; those who fail to make corrections within the time limit shall be fined not less than 100,000 yuan but not more than 500,000 yuan; if the circumstances are serious A fine of not less than 500,000 yuan but not more than 2 million yuan shall be imposed
; If a drug dealer fails to purchase drugs from an enterprise qualified for drug dealership, it shall be ordered to make corrections, the illegally purchased drugs and illegal income shall be confiscated, and a fine of not less than two times but not more than ten times the value of the illegally purchased drugs shall be imposed; if the circumstances are serious, A fine of not less than ten times but not more than 30 times the value of the goods shall be imposed, and the drug business license shall be revoked; if the value of the goods is less than 50,000 yuan, it shall be calculated as 50,000 yuan
.
In January 2022, the Liaoning Provincial Food and Drug Administration imposed a fine of 1.
25 million yuan on the chain pharmacy in accordance with the above-mentioned regulations, and imposed an administrative penalty on the company's legal representative to ban the company's legal representative from engaging in drug production and business activities for life
.
Illegal drug purchases frequently occur
.
On April 13, the Yunnan Food and Drug Administration announced a number of typical cases.
A chain pharmacy was fined 1 million yuan for failing to establish true and complete purchase and sales records and for failing to achieve full control of related drugs
.
On March 22, a news from China.
com.
cn reported that a chain pharmacy in Guangzhou had been queuing up to buy prepared medicines from a medical mechanism and sold them online.
It was suspected of illegally buying and selling medicines, and was fined nearly 600,000 yuan by the regulatory authorities on March 2, According to the Consumer Quality News, a pharmacy in Jinniu District, Chengdu purchased atorvastatin, rosuvastatin and other drugs from personal channels, and was filed by the regulatory authorities, and the illegal gains were confiscated and fined 100,000 yuan
.
Why does this kind of phenomenon happen so often? With this question in mind, Cyberblue - pharmacy managers consulted relevant people and learned that some pharmacies usually take risks and take the initiative to illegally purchase drugs in order to obtain higher profits
.
Take the example of "incomplete information on drug purchases" in illegal drug purchases, which are generally related to three illegal acts of pharmacies: 1.
Illegal collusion
.
Many medicines are controlled for sale, and the prices are different in different regions.
Pharmacies choose to buy low-priced types of drugs, and the drugs that are sold do not carry invoices, which leads to incomplete drug purchase information in pharmacies
.
2.
Purchase of recycled medicines
.
Pharmacies buy recycled medicines from drug dealers at low prices (drugs that are re-entered into the market through medical insurance coverage), most of these drugs are chronic disease medical insurance drugs, purchased and sold through formal channels, pharmacy profit Weibo, some drugs even negative gross profit, If it is replaced with recycled drugs, the gross profit can be increased to about 30%.
Since chronic disease drugs are the main category, the profit of pharmacies selling recycled drugs is considerable
.
3.
Peer purchase
.
Some medicines are only available in their peers, and they are sold very cheaply.
Pharmacies may purchase them as customers through online platforms, and then put them in their own stores for secondary sales
.
However, there is one more special reason
.
Some pharmacies disrupted the market price order, and were stopped by upstream channels due to sales control regulations.
In order to keep their sales share, pharmacies had to continue to mix products.
.
In addition, some chain pharmacies will take unfair competition measures in the face of competitors dumping drugs at low prices, and buy a large number of dumped drugs, so as to deplete the gross profit of competitors' stores.
It also belongs to "illegal drug purchase"
.
The special inspection starts for 8 months.
Recently, the Drug Supervision Department of the State Food and Drug Administration held a working meeting on the special inspection of drug distribution and use
.
The meeting requested that in 2022, the supervision of drug operation should focus on 6 tasks, including "strict investigation and severe punishment, and comprehensive implementation of special inspection requirements for operation and use"
.
In this context, many provinces across the country have successively released the 2022 drug business inspection work plan.
For retail pharmacies, the plan includes a number of special inspections such as "purchasing and selling links", and some provinces have also clarified the special inspection cycle, which is generally 8 months
.
On April 24, the Jiangsu Food and Drug Administration issued an announcement requiring the deployment of special inspections on drug distribution and use.
This special inspection will last for 8 months, starting in April and ending in November
.
The Jiangsu Food and Drug Administration emphasized that it should focus on the source of drug purchases, and focus on the purchase and sale of illegal channels, fraudulent purchases of state-controlled drugs, etc.
Issues such as purchasing medicines by licensed entities and individuals, operating medicines beyond the scope of business, exceeding business methods, and fictitious sources of medicines
.
A few days ago, the Shandong Provincial Food and Drug Administration issued the "Provincial Drug Operation Special Inspection Work Plan", stating that it is necessary to organize a special inspection of drug operation throughout the province, of which "drug purchase sources" are one of the key points of the inspection
.
According to the requirements of the document, the special inspection should be completed before the end of November this year, with a cycle of about 8 months
.
According to incomplete statistics, Jiangsu, Shandong, Shanxi, Ningxia, Liaoning, Shaanxi and other provinces and cities have released 2022 drug business inspection plans, all requiring regulatory authorities to strictly inspect drug purchases and sales in pharmacies
.
In addition, according to the relevant provisions of the new "Drug Administration Law", pharmacies who purchase drugs from illegal channels will be fined at least 100,000 yuan; if the circumstances are serious, the fine will start at 500,000 yuan.
.
In order to avoid heavy fines caused by "illegal channel purchase of drugs", pharmacies must pay attention to the following points when purchasing drugs: 1.
Carefully check the relevant qualifications of the enterprises that purchase drugs, and must ensure that the pharmacies are purchased from qualified enterprises.
Purchase of medicines (except for the purchase of Chinese herbal medicines that have not been subject to approval management)
.
2.
For the purchase of drugs, a purchase inspection and acceptance system shall be established and implemented, and the drug qualification certificate and other marks shall be verified.
If the drug does not meet the prescribed requirements, it shall not be purchased and sold
.
3.
Pharmacies should have true and complete purchase and sales records, including the generic name of the drug, dosage form, specifications, product batch number, expiration date, marketing license holder, manufacturer, purchase and sale unit, purchase and sale quantity, purchase and sale price, purchase and sale date and Other contents stipulated by the drug regulatory department of the State Council
.